Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

NCT02347111 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Flecainide
DRUG: Sotalol

Sponsor

University of Illinois at Chicago

Collaborators

[object Object]